Bioceres press release (NASDAQ:BIOX): Q1 net loss was $5.3 million and Adjusted EBITDA was $8.5 million. Revenue of $93.3M (-20.0% Y/Y).
More on Bioceres
Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices Genetically modified wheat moves closer in U.S. after Bioceres grain deemed safe